December 20, 1996 |
Merck & Co. and Rhone-Poulenc said they are combining their animal health businesses in a joint venture, creating the world's largest maker of medicines for pets and livestock. The venture, to be called Merial Animal Health, will have yearly sales of about $1.7 billion, leapfrogging Pfizer Inc.'s business to become the world leader in the $10.7-billion market.
March 14, 1996
ADM, Rhone-Poulenc Form Global Feed Venture: Archer-Daniels-Midland Co. and France's Rhone-Poulenc Animal Nutrition plan to create a global joint venture that will make supplements for animal feed. The venture is expected to generate annual sales of nearly $500 million. Rhone-Poulenc Animal Nutrition is a unit of France's Rhone-Poulenc. The companies said the venture will manufacture premixes, which are blends of amino acids, vitamins, medicinal additives and trace elements, for adding to feed.
November 28, 1998
* France's Rhone-Poulenc and Germany's Hoechst are expected to announce a merger of their drug and agricultural-chemical businesses as early as Monday, sources told Reuters. The merger would create the world's largest "life sciences" group, with a combined stock market value of about $46.78 billion. American depositary receipts of Hoechst rose 25 cents to close at $44.63 and Rhone-Poulenc's rose $1.06 to close at $51.19 on the NYSE.
June 27, 1997 |
The French parent of Rhone-Poulenc Rorer said it is considering a $4.3-billion offer to buy the remaining third of the U.S. drug maker and spin off its own chemicals and fibers business. The move, a sign that parent Rhone-Poulenc wants a larger share of the lucrative Collegeville, Pa., pharmaceutical company's profit, will be considered at the company's board meeting Wednesday. The companies have a "standstill" agreement that bars any acquisition until after the end of next month.
November 14, 1986
The Danbury, Conn.-based chemical firm said it has reached a definitive agreement to sell the business to the U.S. subsidiary of Rhone-Poulenc S.A., a major French manufacturer of chemicals and pesticides, for $575 million in cash. The sale does not include the agricultural production facilities of Union Carbide India Ltd. Union Carbide said it does not expect to post any material gain or loss on its earnings statement as a result of the sale.
October 11, 1990 |
The French chemical and pharmaceutical giant Rhone-Poulenc SA said today it will slash 3,500 jobs from its Brazilian work force due to government austerity measures that are crimping business activity there. Voluntary layoffs are being conducted at the Sao Paolo-based Rhodia SA, which makes chemicals, fibers and medical products, a company spokeswoman said. "People that leave simply won't be replaced," she said.